Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy

Satoshi Higuchi1, Yuichiro Minami1, Morio Shoda1

  • 1Department of Cardiology Tokyo Women's Medical University Tokyo Japan.

Insights

First-degree atrioventricular block (AVB) is linked to increased risk of death in hypertrophic cardiomyopathy (HCM) patients. This finding highlights AVB as a potential predictor of adverse cardiac events in HCM.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease with variable prognosis.
  • The association between first-degree atrioventricular block (AVB) and life-threatening events in HCM patients is not well-established.
  • Identifying novel risk factors for adverse outcomes in HCM is crucial for patient management.

Purpose of the Study:

  • To investigate the association between first-degree AVB and HCM-related death.
  • To determine if first-degree AVB predicts sudden death or potentially lethal arrhythmic events in HCM patients.

Main Methods:

  • Retrospective analysis of 414 HCM patients.
  • Classification based on P-R interval (≥200 ms) for first-degree AVB.
  • Assessment of HCM-related death, including sudden death, lethal arrhythmias, heart failure, and stroke.

Main Results:

  • First-degree AVB was present in 23.2% of patients.
  • Over 8.8 years median follow-up, 13.5% experienced HCM-related deaths.
  • First-degree AVB independently predicted HCM-related death (aHR 2.41) and sudden death/lethal arrhythmias (aHR 2.60).

Conclusions:

  • First-degree AVB is an independent predictor of HCM-related mortality.
  • This finding may aid in risk stratification for patients with hypertrophic cardiomyopathy.
  • Further research is warranted to explore the mechanisms linking AVB and adverse outcomes in HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
384
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
375